OSTEOP
MCID: OST002
MIFTS: 64

Osteoporosis (OSTEOP) malady

Categories: Genetic diseases, Bone diseases

Aliases & Classifications for Osteoporosis

Aliases & Descriptions for Osteoporosis:

Name: Osteoporosis 54 38 12 24 66 52 41 42 14 69
Osteoporosis, Postmenopausal 54 42 69
Postmenopausal Osteoporosis 66 29
Osteoporosis, Involutional 54 13
Bone Mineral Density Variation Qtl, Osteoporosis 54
Osteoporosis, Postmenopausal, Susceptibility 54
Osteoporosis Postmenopausal 52
Involutional Osteoporosis 66
Osteoporosis, Senile 69
Senile Osteoporosis 66
Osteop 66

Characteristics:

HPO:

32
osteoporosis:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 54 166710
Disease Ontology 12 DOID:11476
ICD10 33 M81.0 M80.0
ICD9CM 35 733.0 733.00
NCIt 47 C3298
UMLS 69 C0029456

Summaries for Osteoporosis

MedlinePlus : 41 osteoporosis is a disease that thins and weakens the bones. your bones become fragile and break easily, especially the bones in the hip, spine, and wrist. in the united states, millions of people either already have osteoporosis or are at high risk due to low bone mass. anyone can develop osteoporosis, but it is more common in older women. risk factors include getting older being small and thin having a family history of osteoporosis taking certain medicines being a white or asian woman having low bone density osteoporosis is a silent disease. you might not know you have it until you break a bone. a bone mineral density test is the best way to check your bone health. to keep bones strong, eat a diet rich in calcium and vitamin d, exercise, and do not smoke. if needed, medicines can also help. it is also important to try to avoid falling down. falls are the number one cause of fractures in older adults. nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Osteoporosis, also known as osteoporosis, postmenopausal, is related to idiopathic juvenile osteoporosis and osteoporosis-pseudoglioma syndrome, and has symptoms including angina pectoris, back pain and muscle cramp. An important gene associated with Osteoporosis is COL1A2 (Collagen Type I Alpha 2 Chain). The drugs Progesterone and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include Bone and Bone.

Disease Ontology : 12 A bone resorption disease characterized by decreased density of normally mineralized bone which results_in the thinning of bone tissue and decreased mechanical strength.

UniProtKB/Swiss-Prot : 66 Osteoporosis: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs.

Wikipedia : 71 Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. It is the... more...

Description from OMIM: 166710

Related Diseases for Osteoporosis

Diseases in the Osteoporosis family:

Osteoporosis, Early-Onset Autosomal Dominant Juvenile Primary Osteoporosis

Diseases related to Osteoporosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 317)
id Related Disease Score Top Affiliating Genes
1 idiopathic juvenile osteoporosis 12.4
2 osteoporosis-pseudoglioma syndrome 12.4
3 glucocorticoid-induced osteoporosis 12.2
4 nephrolithiasis/osteoporosis, hypophosphatemic, 2 12.1
5 nephrolithiasis/osteoporosis, hypophosphatemic, 1 12.1
6 juvenile primary osteoporosis 12.1
7 bone mineral density qtl18, osteoporosis 11.9
8 osteoporosis and oculocutaneous hypopigmentation syndrome 11.8
9 osteoporosis, early-onset autosomal dominant 11.8
10 bone mineral density qtl 12, osteoporosis 11.7
11 hajdu-cheney syndrome 11.7
12 amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis and acidosis 11.7
13 dominant hypophosphatemia with nephrolithiasis or osteoporosis 11.7
14 osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 11.7
15 cutis laxa osteoporosis 11.7
16 macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 11.7
17 acroosteolysis dominant type 11.3
18 werner syndrome 11.1
19 lysinuric protein intolerance 11.1
20 rickets 11.0
21 bone fracture 11.0
22 anorexia nervosa 10.9
23 severe congenital neutropenia 10.9
24 osteopetrosis 10.9
25 mental retardation, x-linked, snyder-robinson type 10.9
26 winchester syndrome 10.8
27 pituitary adenoma, acth-secreting 10.8
28 multicentric osteolysis, nodulosis, and arthropathy 10.8
29 hyaline fibromatosis syndrome 10.7
30 osteogenesis imperfecta, type xiii 10.7
31 pigmented nodular adrenocortical disease, primary, 4 10.7
32 dyskeratosis congenita, autosomal dominant 2 10.7
33 dyskeratosis congenita, autosomal recessive 5 10.7
34 dyskeratosis congenita, autosomal recessive 1 10.7
35 wolcott-rallison syndrome 10.7
36 osteogenesis imperfecta, type xii 10.7
37 premature aging okamoto type 10.7
38 dyskeratosis congenita, autosomal dominant 1 10.6
39 estrogen resistance 10.6
40 mucolipidosis iii alpha/beta 10.6
41 pigmented nodular adrenocortical disease, primary, 1 10.6
42 geroderma osteodysplasticum 10.6
43 hyperparathyroidism-jaw tumor syndrome 10.6
44 singleton merten syndrome 10.6
45 dyskeratosis congenita, autosomal dominant 3 10.6
46 acth-independent macronodular adrenal hyperplasia 10.6
47 prader-willi habitus, osteopenia, and camptodactyly 10.6
48 hyperparathyroidism 3 10.6
49 stuve-wiedemann syndrome/schwartz-jampel type 2 syndrome 10.6
50 pigmented nodular adrenocortical disease, primary, 3 10.6

Comorbidity relations with Osteoporosis via Phenotypic Disease Network (PDN): (show top 50) (show all 85)


Active Peptic Ulcer Disease Acute Cor Pulmonale
Acute Cystitis Adrenal Cortical Hypofunction
Alzheimer Disease Anxiety Disorder
Aortic Atherosclerosis Aplastic Anemia
Asthma, Phf11-Related Benign Essential Hypertension
Bronchiectasis Bronchitis
Bronchopneumonia Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Myocardial Ischemia Chronic Pulmonary Heart Disease
Chylomicron Retention Disease Conjunctivitis
Cystitis Decubitus Ulcer
Deficiency Anemia Dermatomycosis
Dyskinesia of Esophagus Dysthymic Disorder
Esophagitis Femoral Vein Thrombophlebitis
Gastroesophageal Reflux Generalized Anxiety Disorder
Generalized Atherosclerosis Heart Disease
Hyperparathyroidism Hypertension, Essential
Hyperuricemia, Pulmonary Hypertension, Renal Failure, and Alkalosis Hypothyroidism
Idiopathic Interstitial Pneumonia Idiopathic Juvenile Osteoporosis
Inflammatory Bowel Disease 1 Intervertebral Disc Disease
Intestinal Obstruction Iron Deficiency Anemia
Irritable Bowel Syndrome Left Ventricular Outflow Tract Obstruction
Macular Degeneration, Age-Related, 1 Marasmus
Monoclonal Paraproteinemia Neurogenic Bladder
Nutritional Deficiency Disease Opiate Dependence

Graphical network of the top 20 diseases related to Osteoporosis:



Diseases related to Osteoporosis

Symptoms & Phenotypes for Osteoporosis

Symptoms by clinical synopsis from OMIM:

166710

Clinical features from OMIM:

166710

Human phenotypes related to Osteoporosis:

32
id Description HPO Frequency HPO Source Accession
1 osteoporosis 32 HP:0000939

UMLS symptoms related to Osteoporosis:


angina pectoris, back pain, muscle cramp, pelvic pain, sciatica, tremor, equilibration disorder

Drugs & Therapeutics for Osteoporosis

Drugs for Osteoporosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 616)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Progesterone Approved, Vet_approved Phase 4,Phase 3,Phase 2 57-83-0 5994
2
Tacrolimus Approved, Investigational Phase 4,Phase 3 104987-11-3 445643 439492
3
Testosterone Approved, Investigational Phase 4,Phase 2,Phase 3 58-22-0 6013
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-28-2 5757 53477783
5
Mycophenolic acid Approved Phase 4,Phase 3 24280-93-1 446541
6
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3 128794-94-5 5281078
7
Alendronate Approved Phase 4,Phase 2,Phase 3,Phase 1 121268-17-5, 66376-36-1 2088
8
Zoledronic acid Approved Phase 4,Phase 3,Phase 2 118072-93-8 68740
9
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-24-8 5755
10
Etidronic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 7414-83-7, 2809-21-4 3305
11
Calcium carbonate Approved Phase 4,Phase 3,Phase 2,Phase 1 471-34-1
12
Letrozole Approved, Investigational Phase 4,Phase 3,Phase 2 112809-51-5 3902
13
Teriparatide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 52232-67-4 16133850
14
Anastrozole Approved, Investigational Phase 4,Phase 3,Phase 2 120511-73-1 2187
15
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
16
Denosumab Approved Phase 4,Phase 3,Phase 2,Phase 1 615258-40-7
17
Benzocaine Approved Phase 4,Phase 3,Early Phase 1 1994-09-7, 94-09-7 2337
18
Menthol Approved Phase 4,Early Phase 1 2216-51-5 16666
19
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2 83-43-2 6741
20
Medroxyprogesterone acetate Approved, Investigational Phase 4,Phase 3,Phase 1 71-58-9
21
Methyltestosterone Approved Phase 4,Phase 2,Phase 3 58-18-4 6010
22
Prednisone Approved, Vet_approved Phase 4,Phase 3 53-03-2 5865
23
Potassium Citrate Approved, Vet_approved Phase 4,Phase 3
24
Ethanol Approved Phase 4 64-17-5 702
25
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
26
Pioglitazone Approved, Investigational Phase 4,Phase 2 111025-46-8 4829
27
Ritonavir Approved, Investigational Phase 4,Phase 3 155213-67-5 392622
28
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
29
Lopinavir Approved Phase 4 192725-17-0 92727
30
Efavirenz Approved, Investigational Phase 4 154598-52-4 64139
31
Epinephrine Approved, Vet_approved Phase 4,Phase 2,Phase 3 51-43-4 5816
32
Fluvastatin Approved Phase 4 93957-54-1 1548972
33
Montelukast Approved Phase 4 158966-92-8 5281040
34
Tenofovir Approved, Investigational Phase 4,Phase 3,Phase 2 147127-20-6 464205
35
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
36
Acetaminophen Approved Phase 4,Phase 3,Phase 1 103-90-2 1983
37
Lamivudine Approved, Investigational Phase 4,Phase 3 134678-17-4 60825
38
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 2 169590-42-5 2662
39
Ibuprofen Approved Phase 4,Phase 1 15687-27-1 3672
40
Gliclazide Approved Phase 4 21187-98-4 3475
41
Metformin Approved Phase 4,Phase 3,Phase 2 657-24-9 14219 4091
42
Valproic Acid Approved, Investigational Phase 4 99-66-1 3121
43
Losartan Approved Phase 4 114798-26-4 3961
44
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
45
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
46
Tibolone Approved Phase 4,Phase 3,Phase 2 5630-53-5
47
Tetracycline Approved, Vet_approved Phase 4,Phase 2 60-54-8 5353990
48
Ribavirin Approved Phase 4 36791-04-5 37542
49
Adalimumab Approved Phase 4,Phase 3,Phase 2 331731-18-1 16219006
50
Etanercept Approved, Investigational Phase 4,Phase 3,Phase 1 185243-69-0

Interventional clinical trials:

(show top 50) (show all 1648)
id Name Status NCT ID Phase
1 Osteoporosis and Dental Implant Unknown status NCT00727493 Phase 4
2 Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis Unknown status NCT01675297 Phase 4
3 Clinical Comparison of Efficacy and Safety of Two Teriparatide Formulations: Osteofortil and Forteo Unknown status NCT01945788 Phase 4
4 To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women Unknown status NCT01904110 Phase 4
5 The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels Unknown status NCT01765010 Phase 4
6 Analgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Vertebral Fractures Unknown status NCT01482858 Phase 4
7 Effects of Omega-3 Fatty Acids on Bone and Frailty Unknown status NCT00634686 Phase 4
8 The Effects of Potassium Citrate on Bone Metabolism Unknown status NCT00357331 Phase 4
9 Denosumab in Enhancement of Bone Bonding of Hip Prosthesis in Postmenopausal Women Unknown status NCT01926158 Phase 4
10 Multi-centre Clinical Trial on Hormone Replacement Treatment in China Unknown status NCT01698164 Phase 4
11 The Effect of Zoledronic Acid to Bone Fusion and Bone Metabolism of Patients With Lumbar Degenerative Disease After Lumbar Interbody Fusion Unknown status NCT01310465 Phase 4
12 The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study Unknown status NCT01323608 Phase 4
13 Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis Unknown status NCT02484508 Phase 4
14 Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen Unknown status NCT01560572 Phase 4
15 Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace) Unknown status NCT01908556 Phase 4
16 Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? Unknown status NCT00299572 Phase 4
17 A Study Comparing Outcomes of Kidney Transplants in Patients on Steroids Versus Those Who Discontinue Steroids Unknown status NCT00273559 Phase 4
18 Changes in Knee Articular Cartilage Volume in Women on Aromatase Inhibitors Unknown status NCT00111241 Phase 4
19 Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis Completed NCT01544894 Phase 4
20 Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate Completed NCT00327990 Phase 4
21 Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM) Completed NCT00479037 Phase 4
22 Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window? Completed NCT01166958 Phase 4
23 ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis. Completed NCT00545090 Phase 4
24 Teriparatide Treatment in Patients With Inherited Osteoporosis Completed NCT01360424 Phase 4
25 Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use Completed NCT00221299 Phase 4
26 Danish Osteoporosis Prevention Study Completed NCT00252408 Phase 4
27 Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis Completed NCT01465568 Phase 4
28 A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) Completed NCT00545363 Phase 4
29 STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES) Completed NCT00583518 Phase 4
30 HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids. Completed NCT00376662 Phase 4
31 The Prevalence of Osteoporosis in Hemodialysis Patients Completed NCT00308828 Phase 4
32 High Dosage Vitamin D and Osteoporosis Completed NCT00491920 Phase 4
33 Prevention of Osteoporosis in Breast Cancer Survivors Completed NCT00567606 Phase 4
34 Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis Completed NCT00405392 Phase 4
35 A Study of Prevention and Treatment of Postmenopausal Osteoporosis in Chinese Women Completed NCT00860964 Phase 4
36 Effects of Teriparatide or Denosumab on Bone in Postmenopausal Women With Osteoporosis Completed NCT01753856 Phase 4
37 A Study of Teriparatide in Japanese Osteoporosis Patients Completed NCT01430104 Phase 4
38 Evaluation of the Effects of Teriparatide on Skeleton Images in Postmenopausal Women With Osteoporosis Completed NCT00259298 Phase 4
39 A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia Completed NCT02604836 Phase 4
40 2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis Completed NCT00191425 Phase 4
41 A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. Completed NCT00545051 Phase 4
42 A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo Completed NCT00148915 Phase 4
43 A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis Completed NCT02598440 Phase 4
44 BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis Completed NCT00545909 Phase 4
45 A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis Completed NCT02598934 Phase 4
46 A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate) Completed NCT00303485 Phase 4
47 Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) Completed NCT00271713 Phase 4
48 SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis. Completed NCT00545480 Phase 4
49 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment Completed NCT00551174 Phase 4
50 A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva Completed NCT00081653 Phase 4

Search NIH Clinical Center for Osteoporosis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Osteoporosis cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Osteoporosis:
PREOB

Cochrane evidence based reviews: osteoporosis

Genetic Tests for Osteoporosis

Genetic tests related to Osteoporosis:

id Genetic test Affiliating Genes
1 Postmenopausal Osteoporosis 29
2 Osteoporosis 24 VDR

Anatomical Context for Osteoporosis

MalaCards organs/tissues related to Osteoporosis:

39
Bone, Testes, Skin, Bone Marrow, Breast, Prostate, Heart
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Osteoporosis:
id Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Mononucleated Osteoclasts Affected by disease
2 Bone Bone Marrow Multinucleated Osteoclasts Affected by disease
3 Blood Hematopoietic Bone Marrow Osteoclast Precursor Cells Affected by disease

Publications for Osteoporosis

Articles related to Osteoporosis:

(show top 50) (show all 2496)
id Title Authors Year
1
Content Validity of a Short Calcium Intake List to Estimate Daily Dietary Calcium Intake of Patients with Osteoporosis. ( 28083636 )
2017
2
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis. ( 28079119 )
2017
3
Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. ( 28529755 )
2017
4
A novel osteoporosis model with ascorbic acid deficiency in Akr1A1 gene knockout mice. ( 28060768 )
2017
5
Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis. ( 28512501 )
2017
6
Recent advances in the management of osteoporosis. ( 28529724 )
2017
7
Misdiagnosis of vertebral fractures on local radiographic readings of the multicentre POINT (Prevalence of Osteoporosis in INTernal medicine) study. ( 28511873 )
2017
8
Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice. ( 28501578 )
2017
9
TNF-I+ Promotes Osteoclastogenesis through JNK Signaling-Dependent Induction of Semaphorin3D Expression in Estrogen-Deficiency Induced Osteoporosis. ( 28059444 )
2017
10
Romosozumab for the treatment of osteoporosis. ( 28064540 )
2017
11
Cancer Risk in Patients with Osteoporosis: A Population-Based Cohort Study. ( 28044464 )
2017
12
A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis. ( 27679514 )
2017
13
Segmental polymethylmethacrylate-augmented fenestrated pedicle screw fixation for lumbar spondylolisthesis in patients with osteoporosis - A case series and review of literature. ( 28084247 )
2017
14
The prevalence of osteoporosis and the rate of bone loss in Korean adults: the Chungju metabolic disease cohort (CMC) study. ( 28083665 )
2017
15
Psoriasis and osteoporosis: the debate continues. ( 28504373 )
2017
16
Glossodynia After Osteoporosis Treatment. ( 28502340 )
2017
17
Spinal surgery in patients with significant osteoporosis: The therapeutic advances and research perspectives. ( 28084248 )
2017
18
The Prevalence and Risk Factors of Osteoporosis among a Saudi Female Diabetic Population. ( 28507624 )
2017
19
Greater Intake of Fruit and Vegetables Is Associated with Greater Bone Mineral Density and Lower Osteoporosis Risk in Middle-Aged and Elderly Adults. ( 28045945 )
2017
20
Osteoporosis management in residential care: How internal and family medicine resident physicians translate evidence into practice. ( 28500202 )
2017
21
Prospect of Combination and Sequential therapies for postmenopausal osteoporosis. ( 28521691 )
2017
22
Depression and Osteoporosis: A Study of 100 Patients. ( 28534600 )
2017
23
Effect of intervention initiation timing of pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats. ( 28510268 )
2017
24
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis. ( 27743017 )
2017
25
Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats. ( 27917698 )
2017
26
Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2A years. ( 28058444 )
2017
27
OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS. ( 28065194 )
2017
28
Prevalence of Osteoporosis and Effectiveness of Screening Test Using Ultrasound Bone Densitometry and Education in a Community-Dwelling Population. ( 28049249 )
2017
29
Osteoporosis Knowledge and Related Health Behavior among Women in Jazan Region, Kingdom of Saudi Arabia. ( 28512276 )
2017
30
Effects of Recombinant Human Growth Hormone for Osteoporosis: Systematic Review and Meta-Analysis. ( 28069090 )
2017
31
ToF-SIMS study of differentiation of human bone-derived stromal cells: new insights into osteoporosis. ( 28516281 )
2017
32
Prevention of postmenopausal osteoporosis in Chinese women: a 5-year, double-blind, randomized, parallel placebo-controlled study. ( 28523945 )
2017
33
LRP5-linked osteoporosis-pseudoglioma syndrome mimicking isolated microphthalmia. ( 28111184 )
2017
34
Effects of acupuncture on quality of life and pain in patients with osteoporosis-a pilot randomized controlled trial: reply to comments by Moran et al. ( 28074449 )
2017
35
Osteoporosis: fracture epidemiology update 2016. ( 28072591 )
2017
36
Pregnancy-associated osteoporosis: a case-control study. ( 28074248 )
2017
37
Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients. ( 28522769 )
2017
38
Combination Therapy of Raloxifene and Alendronate for Treatment of Osteoporosis in Elderly Women. ( 28523260 )
2017
39
Osteoporosis in Stickler syndrome. A new family case with bone histology study. ( 28159459 )
2017
40
Femoral osteoporosis is more common than lumbar osteoporosis in patients with Werner syndrome. ( 28508498 )
2017
41
Osteoporosis-pseudoglioma syndrome: Report of two cases and a manifesting carrier. ( 28145787 )
2017
42
Women's Health: Polycystic Ovarian Syndrome, Menopause, and Osteoporosis. ( 28501236 )
2017
43
Evaluation of Correlation between Salivary Calcium, Alkaline Phosphatase and Osteoporosis- A Prospective, Comparative and Observational Study. ( 28511512 )
2017
44
Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis-A prospective study. ( 27162010 )
2016
45
Recent Clinical Trials in Osteoporosis: A Firm Foundation or Falling Short? ( 27191848 )
2016
46
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2016): Committee of National Societies Abstracts. ( 27188179 )
2016
47
Simultaneous Bilateral Transient Osteoporosis of the Hip without Pregnancy. ( 27648329 )
2016
48
Romosozumab Treatment in Postmenopausal Women with Osteoporosis. ( 27641143 )
2016
49
An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice. ( 27974218 )
2016
50
Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey. ( 27177746 )
2016